(19)
(11) EP 3 122 364 A1

(12)

(43) Date of publication:
01.02.2017 Bulletin 2017/05

(21) Application number: 15768772.4

(22) Date of filing: 27.03.2015
(51) International Patent Classification (IPC): 
A61K 31/57(2006.01)
A61K 47/30(2006.01)
A61K 9/48(2006.01)
(86) International application number:
PCT/US2015/023041
(87) International publication number:
WO 2015/148952 (01.10.2015 Gazette 2015/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 28.03.2014 US 201461972068 P

(71) Applicant: TherapeuticsMD, Inc.
Boca Raton, FL 33487 (US)

(72) Inventors:
  • CACACE, Janice
    St Petersburg, FL 33702 (US)
  • PERSICANER, Peter
    Boca Raton, FL 33496 (US)
  • THORSTEINSSON, Thorsteinn
    Boynton Beach, FL 33436-1309 (US)
  • SANCILIO, Frederick
    Palm Beach Gardens, FL 33418 (US)
  • AMADIO, Julia
    Boca Raton, FL 33486 (US)
  • BERNICK, Brian
    Boca Raton, FL 33496 (US)

(74) Representative: Main, Malcolm Charles 
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) PROGESTERONE FORMULATIONS